Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

BACKGROUND: This open-label phase III trial evaluated efficacy and safety of S-1 plus cisplatin vs. cisplatin alone as first-line chemotherapy in patients with stage IVB, recurrent, or persistent cervical cancer. METHODS: Patients were randomised (1:1) to S-1 plus cisplatin (study group) or cisplati...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Yoichi, Ochiai, Kazunori, Lim, Soyi, Aoki, Daisuke, Kamiura, Shoji, Lin, Hao, Katsumata, Noriyuki, Cha, Soon-Do, Kim, Jae-Hoon, Kim, Byoung-Gie, Hirashima, Yasuyuki, Fujiwara, Keiichi, Kim, Young-Tak, Kim, Seok Mo, Chung, Hyun Hoon, Chang, Ting-Chang, Kamura, Toshiharu, Takizawa, Ken, Takeuchi, Masahiro, Kang, Soon-Beom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162273/
https://www.ncbi.nlm.nih.gov/pubmed/30072745
http://dx.doi.org/10.1038/s41416-018-0206-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162273/
https://www.ncbi.nlm.nih.gov/pubmed/30072745
http://dx.doi.org/10.1038/s41416-018-0206-7

Ejemplares similares